Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53--an acrobat in tumorigenesis

U M Moll1, L M Schramm

  • 1Department of Pathology, Health Sciences Center, State University of New York at Stony Brook, 11794-8691, USA.

Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists
|March 6, 1998
PubMed
Summary

The p53 tumor suppressor protein is crucial for genomic integrity, mediating cell cycle arrest or apoptosis after DNA damage. Its disruption is linked to most human cancers and impacts therapy response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial death functions of p53.

Molecular & cellular oncology·2016
Same author

Corrigendum: Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.

Nature·2015
Same author

Expansion of the hematopoietic stem cell compartment is necessary but not sufficient for gain-of-function mutant p53 R248Q to accelerate lymphomagenesis.

Cell death and differentiation·2015
Same author

Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.

Nature·2015
Same author

p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.

Cell death and differentiation·2014
Same author

HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.

Cell death & disease·2014

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The p53 protein is a key regulator of DNA damage response pathways.
  • It functions as a tumor suppressor, maintaining genomic stability.
  • p53 mediates cell cycle arrest or apoptosis following DNA damage.

Purpose of the Study:

  • To elucidate the central role of p53 in genomic integrity and DNA damage control.
  • To explore the mechanisms of p53 inactivation in human cancers.
  • To investigate the implications of p53 loss on cancer development and therapy.

Main Methods:

  • Review of existing literature on p53 function and cancer biology.
  • Analysis of p53's biochemical properties (transcriptional regulation, protein interactions).
  • Examination of experimental models of p53 deficiency and carcinogen exposure.

Main Results:

  • p53 loss leads to genomic instability, increased mutations, and aneuploidy.
  • Disruption of p53 pathway is common in human cancers, often due to mutations or viral products.
  • p53-deficient mice exhibit a high incidence of tumors.
  • Loss of p53 can confer resistance to anticancer therapies.

Conclusions:

  • The p53 pathway is essential for preventing tumorigenesis.
  • Inactivation of p53 is a critical step in the development of many cancers.
  • Understanding p53's role opens avenues for novel p53-based cancer therapies.

Related Experiment Videos